Cancer Center– A Cancer Center Designated by
the National Cancer Institute

Clinical Trials in the Category "Glioma"

Drug Intervention Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
A Study of Pemetrexed in Children With Recurrent Cancer Dr. Neyssa Maria Marina
 Osteosarcoma
Neuroblastoma
Medulloblastoma
Phase 2 of Azixa™ (MPC-6827) for Glioblastoma Multiforme in First or Second Relapse Dr Lawrence Recht
 Brain Cancer
Glioblastoma
BIBW 2992 With or Without Daily Temozolomide For Recurrent Malignant Glioma Dr Lawrence Recht
 Oligodendroglioma
Glioma
Glioblastoma
Low-Dose Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Primitive Neuroectodermal Tumor or Medulloblastoma Paul Graham Fisher
 Central Nervous System Neoplasms
Brain Cancer
Neuroectodermal Tumors
Medulloblastoma



Trials not Recruiting

Study Title
 Principal Investigator Disease Category
Phase II/III Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III)
(No longer recruiting) 		Dr Lawrence Recht
 Central Nervous System Neoplasms
Brain Cancer
Glioblastoma
Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia
(No longer recruiting) 		Dr. Neyssa Marina
 Leukemia
Lymphoma
Neuroblastoma
Medulloblastoma
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
(No longer recruiting) 		Dr. Neyssa Marina
 Central Nervous System Neoplasms
Brain Cancer
Glioma
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
(No longer recruiting) 		Dr. Neyssa Marina
 Central Nervous System Neoplasms
Ependymoma
Brain Cancer
Assessing the suitability of an imaging probe for use in clinical cell and gene therapy trials in cancer and rheumatoid arthritis
(No longer recruiting) 		Sanjiv Sam Gambhir M.D., Ph.D.
 Central Nervous System Neoplasms
Brain Cancer
Glioma
Arthritis, Rheumatoid


The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials.  Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Stanford Medicine Resources:

Footer Links: